Proton Therapy Market Size, Share, Industry Trends and Forecast to 2030

Proton Therapy Market Size & CAGR in 2021

The global proton therapy market had a market size of USD 1.15 billion in 2021, with a Compound Annual Growth Rate (CAGR) of 8.3% from 2021 to 2028. By 2028, the market is expected to reach USD 2.06 billion, showcasing steady growth in the forecast period.

COVID-19 Impact on the Proton Therapy Market

The COVID-19 pandemic had a substantial impact on the proton therapy market in 2020 and 2021. The disruptions in healthcare services, postponement of non-emergency procedures, and constraints on hospital resources led to a decline in the number of proton therapy treatments. However, with the gradual recovery from the pandemic in 2021, the market began to show signs of resurgence as healthcare facilities resumed operations and patients sought treatment.

Proton Therapy Dynamics

Proton therapy is a type of radiation therapy that uses protons to target cancer cells with precision, reducing damage to surrounding healthy tissue. The adoption of proton therapy is driven by its ability to deliver high doses of radiation to tumors while minimizing side effects, making it particularly suitable for treating pediatric cancers and certain adult cancers.

Factors such as technological advancements in proton therapy systems, increasing prevalence of cancer, growing awareness about the benefits of proton therapy, and favorable reimbursement policies are fueling the growth of the proton therapy market. However, challenges such as high treatment costs, limited access to proton therapy facilities, and competition from other radiation therapy modalities pose constraints to market growth.

Segments and Related Analysis

By Treatment Type

The proton therapy market is segmented based on treatment type into single-room systems and multi-room systems. Single-room systems are more compact and cost-effective, making them suitable for smaller healthcare facilities and clinics. On the other hand, multi-room systems are larger and more specialized, catering to hospitals and cancer centers with higher patient volumes.

By Application

Proton therapy is used to treat various types of cancers, including prostate cancer, breast cancer, lung cancer, brain tumors, and pediatric cancers. Each application requires specific treatment protocols and equipment settings to deliver optimal therapeutic outcomes.

By Region Analysis

North America

North America is the largest market for proton therapy, driven by high healthcare expenditure, advanced infrastructure, and a large patient population with cancer. The United States leads the region in the adoption of proton therapy, with several proton therapy centers established across the country.

Europe

Europe is a significant market for proton therapy, with countries like Germany, the United Kingdom, and France at the forefront of adoption. The European market is characterized by collaborations between healthcare providers, research institutions, and technology developers to enhance the delivery of proton therapy services.

Asia Pacific

The Asia Pacific region is witnessing rapid growth in the proton therapy market, driven by increasing investments in healthcare infrastructure, rising cancer prevalence, and growing awareness about advanced treatment options. Countries like Japan, South Korea, and China are key markets for proton therapy in the region.

Key Market Players and Competitive Landscape

Some of the prominent players in the global proton therapy market include Varian Medical Systems, Hitachi Ltd., IBA Proton Therapy, Sumitomo Heavy Industries Ltd., and Mevion Medical Systems. These companies are actively involved in product development, strategic partnerships, and market expansion initiatives to strengthen their foothold in the competitive landscape.

Recent Happenings in the Proton Therapy Market

- In 2021, Varian Medical Systems introduced the ProBeam 360° proton therapy system, a next-generation treatment platform that offers advanced imaging capabilities and precise dose delivery for improved patient outcomes.

- In 2022, Hitachi Ltd. collaborated with a leading healthcare provider to establish a proton therapy center in a key market, expanding access to innovative cancer treatment options and driving market growth.

- Mevion Medical Systems received regulatory approval for its compact proton therapy system in multiple regions, enhancing the accessibility of proton therapy services and addressing unmet healthcare needs.